These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1408191)

  • 21. p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis.
    Shin DM; Charuruks N; Lippman SM; Lee JJ; Ro JY; Hong WK; Hittelman WN
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):603-9. PubMed ID: 11401909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 mutations in head and neck cancer: new data and evaluation of mutational spectra.
    Olshan AF; Weissler MC; Pei H; Conway K
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):499-504. PubMed ID: 9232336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Refined characterization of head and neck squamous cell carcinomas expressing a seemingly wild-type p53 protein.
    Leng K; Schlien S; Bosch FX
    J Oral Pathol Med; 2006 Jan; 35(1):19-24. PubMed ID: 16393249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas.
    Berenson JR; Yang J; Mickel RA
    Oncogene; 1989 Sep; 4(9):1111-6. PubMed ID: 2476705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oncogenes and tumor suppressor genes in head and neck squamous cell carcinomas].
    Maestro R; Dolcetti R
    Acta Otorhinolaryngol Ital; 1996 Jun; 16(3 Suppl 54):21-6. PubMed ID: 9036736
    [No Abstract]   [Full Text] [Related]  

  • 28. Oncogenes in head and neck cancer.
    Irish JC; Bernstein A
    Laryngoscope; 1993 Jan; 103(1 Pt 1):42-52. PubMed ID: 8421418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region.
    Hauser U; Balz V; Carey TE; Grénman R; Van Lierop A; Scheckenbach K; Bier H
    Head Neck; 2002 Sep; 24(9):868-73. PubMed ID: 12211051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas.
    Schuuring E; Verhoeven E; Mooi WJ; Michalides RJ
    Oncogene; 1992 Feb; 7(2):355-61. PubMed ID: 1532244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
    Lammie GA; Fantl V; Smith R; Schuuring E; Brookes S; Michalides R; Dickson C; Arnold A; Peters G
    Oncogene; 1991 Mar; 6(3):439-44. PubMed ID: 2011398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oncogenes and their significance for head and neck cancers].
    Issing WJ; Wustrow TP; Heppt W
    HNO; 1992 Aug; 40(8):283-91. PubMed ID: 1517116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of tumor suppressor gene p53 and Rb in patients with epidermoid carcinoma of the head and neck].
    Schipper JH; Kelker W
    HNO; 1994 May; 42(5):270-4. PubMed ID: 8050915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
    Papadimitrakopoulou VA; Oh Y; El-Naggar A; Izzo J; Clayman G; Mao L
    Clin Cancer Res; 1998 Mar; 4(3):539-44. PubMed ID: 9533520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
    Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
    J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ras mutations and expression in head and neck squamous cell carcinomas.
    Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
    Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of p53 protein is common in premalignant head and neck lesions.
    Pavelic ZP; Li YQ; Stambrook PJ; McDonald JS; Munck-Wikland E; Pavelic K; Dacic S; Danilovic Z; Pavelic L; Mugge RE
    Anticancer Res; 1994; 14(5B):2259-66. PubMed ID: 7840533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic instability in squamous cell carcinoma of the head and neck.
    Field JK
    Anticancer Res; 1996; 16(4C):2421-31. PubMed ID: 8816845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma.
    Jin C; Jin Y; Gisselsson D; Wennerberg J; Wah TS; Strömbäck B; Kwong YL; Mertens F
    Cytogenet Genome Res; 2006; 115(2):99-106. PubMed ID: 17065789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.